ACS Flashcards

1
Q

How do you diagnose ACS?

A

-Presence of cardiac biomarker, preferably troponin T
AND one of following above 99th percentile:
- Symptoms of MI
- New ischaemic ECG change
- PAthological Q waves develop on ECH
- Imaging - loss of viable myocardium/regional wallmotion abnoramlity
- Intracoronary thrombus detected on angiography or autospy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What other cardiac biomarkers suggest ACS other than troponin T?

A

Myoglobulin
Creatine Kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

WHy is troponin t used when diagnosing ACS?

A

Most sensitive test for MI out of other biomarkers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When do you use Smith modified Sgarbossa criteria

A

When significant pre existing CVD eg CAD makes it difficult to differentiate between prev damage and current MI and there is LBBB or paced MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is teh SMith modified Sgarbossa criteria?

A

≥ 1 lead with ≥1 mm of concordant ST elevation
≥ 1 lead of V1-V3 with ≥ 1 mm of concordant ST depression
≥ 1 lead anywhere with ≥ 1 mm STE and proportionally excessive discordant STE, as defined by ≥ 25% of the depth of the preceding S-wave.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How much ST elevation is required to diagnose posterior MI - leads V7-9

A

0.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What do you need to look for evidence of in an ECG of an inferior or lateral MI?

A

Posterior MI - often missed
Lack of obvious ST elevation - be vigilant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When does posterior MI often occur?

A

As an extension of an inferior or lateral infarct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why are outcomes for posterior MI worse than others?

A

Majority of posterior MIs are extension of inferior or lateral, therefore finding implies much larger area of Myocardial damage, increasing risk of LV dysfunction and death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is an isolated posterior infarction indication for?

A

Emergnecy coronary repurfusion eg stent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Early management for NSTEMI and unstable angina

A

Antiplatelet therapy - 300mg aspirin loading dose then continue
Fondiparinux

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When dont give fondiparinux in NSTEMI/unstable angina

A

high bleeding risk or angiography immediately planned

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Factors when determining bleeidng risk

A

Advancing age, renal impairment, bleeding ocmplications, on anticoags already, low body weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When do you use unfractionated heparin instead of fondiparinux for antithrombin therapy

A

If creatinine above 265 micromoles/L or high bleeding risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What score can you use to predict mortality + risk of CVS events from ACS?

A

GRACE - 6 month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Investigations for NSTEMI/ unstable angina after initial management

A

GRACE score
Hisotry
Exam
12 lead ECG
bloods - Troponin T
Creatinine
Glucose
Haemoglobin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What seperates low and intermediate to high risk for NTEMI/unstable angina?

A

3% mortality in next 6 months - under or above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What to do with low risk patients unstable angina/NSTEMI

A

Conservative management
(aware that some young people benefit from early angiography)

Offer ticagreolor with aspirin
Consider ischaemia test before discharge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

When do you offer clopidogrel instead of ticagrelor/prasugrel for managment of NSTEMI/unstable angina?

A

When theres a high bleeding risk or patient is on oral anticoagulants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

When consider angiography for NSTEMI/unstable angina

A

Ischaemia develops or shown on testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What should you always assess as a last step before rehab in NSTEMI and consider in unstable angina?

A

Left ventricular function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Long term management for NSTEMI/unstable angina

A

Cardiac rehab and secondary prevention
Consider CABG - coronary artery bypass graft - if unable to stent
Lifestyle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When offer angiograph and PCI for NSTEMI/unstable angina

A

INtermediate or high riskm mortality >3% in next 6 month s
Immediate if unstable
If stable consider in next 72 hours if no contraindications eg comorbidity or active bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What to give before PCI

A

Prasugrel (careful if theyre over 75)
Unfractionated heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Associated symptoms with MI

A

-SOB
-Collapse/syncope
-Nausea
-Fear of impending doom
-palpitations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How long does chest pain have to go on for to be an MI

A

> 20 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What causes collapse in MI?

A

arrhytmia or hypotension

28
Q

sIGNS OF MI

A

-Unwell
-Pallor/grey
-Sweaty
Signs of shock
-Hypotension
-Cool peripheries
-Raised cap refill
-Tachycardic
Signs of complications
-Pulmonary oedema
-New murmur
-Arrhtymias
-Hypoxia

29
Q

Non modifiable risk factors MI

A

Male
Age
FHx CAD - before 50 sudden death
Premature menopause

30
Q

Modifiable risk factors for ACS

A

Smoking
T2DM
Hypertension
Dyslipidemia
Obestiy
Physical inactivity

31
Q

What is Troponin T evidence of?

A

Myocardial necrosis

32
Q

What drugs are used for secondary preventuon of MI?

A

DABS
-dual antiplatelet therapy for 1 year - aspirin + ticagrelor, than aspirin lifelong
-ACEis ir ARB
-Beta blockers
-Statins
Aldosterone antagonist - acute MI, HF, LV systolic dysfunction
-Diabetic control and HPTN

33
Q

What is a common cardiac side effect of cyclizine?

A

Tachycardia

34
Q

MOA of fondaparinux

A

Inhibits factor X

35
Q

Which Leads and myocardial area are affected when the proximal LAD is blocked?

A

V1-V2, septal

36
Q

What artery is blocked when there are changes in V3-V4 and what section of the myocardium?

A

Anterior, LAD

37
Q

What leads show changes when the LCx artery is occluded?

A

I + aVL as the lateral part of the myocardium is affected

38
Q

What vessel is occluded in 10% of the population in an Inferior MI?

A

LCx

39
Q

If there are ECG changes in 2, aVF, 3 then what part of the myocardium is affected? Which is the most likely artery to be occluded?

A

INferior, 90% RCA

40
Q

Which arteries can be occluded that cause changes in V5-V6 and why?

A

Distal LAD, LCx or RCA because they supply the apical myocardium

41
Q

Absolute contraindications for fibrinolytic therapy

A

Prev haemorrhagic stroke
Ischaemic stroke in prev 6 months
Central nervous system trauma or neoplasm
Recent <3months major surgery, head injury or major trauma
Active internal bleeding or GI bleeding in last month
Known or suspected aortic dissection
Known bleeding disorder

42
Q

Relative contraindications for fibrinolysis

A

Refractory HPTN >180
TIA last 6 months
Oral anticoags
Pregnant or <1 week pp
Traumatic CPR
Active peptic ulcer disease
Advanced liver disease
Infective endocarditis
Prev allergy to fibrinolytic

43
Q

Features of stable angina

A
  1. Constricting discomfort in the front of the chest, or in the neck, shoulders, jaw and arms
  2. Precipitated by exertion
  3. Relieved by rest or GTN spray in 5 mins
    - Patients with 2 features have atypical, with 1 have non anginal chest pain
    - ECG, CT angiogram
44
Q

Primary prevention of ACS

A

Aspirin 75mg OD
Statin
If diabetic, ACE inhibiotr

45
Q

Angina prevention 1st line

A

Beta blocker or CCB
Alternatives - Isosorbide mononitrate, nicrandil, ivabradine, ranolazine

46
Q

Angina prevention 2nd line

A

Add the type of drug

47
Q

Why use a GTN spray sitting down

A

Vasodilation causes drop in BP, avoid dizziness and fainting

48
Q

How to use GTN spray

A

1-2 puffs wait 5 mins for pain to subside, if doesn’t go again
If no relief on second spray + gets worse call 999

49
Q

What are the sokow-lyon criteria? If positive what does it show?

A

Voltage of S wave in V1
R wave V5 or V6
If both are present >35mm
LVH

50
Q

What is a type I MI

A

Plaque rupture/erosion
+ troponin, new ECG changes

51
Q

Type 2 MI

A

Ishcaemic
+ve biomearkers, new ECG changes

52
Q

Type 3 MI

A

Cardia death in patients with sus MI before cardiac biomarker smapling

53
Q

Type 4 vs 5 MI

A

4 = PCI related
5 = Coronary artery bypass graft surgery related

54
Q

What ST elevation required in standard leads for STEMI

A

1mm

55
Q

What are the non standard leads in STEMI and what ST elevation required for diagnosis

A

V2-3 = 2mm in men > 40
>1.5mm in women
V7-9 - post leads - 0.5mm

56
Q

Differentials for ST elevation groups of causes

A

Infection
Arrhytmia
Structural
Electolyte
Vascular

57
Q

Infective and structural causes of ST elevation

A
  • Pericarditis
  • Myocarditis
    -LV hypertrophy
    -Takutsobos CM
58
Q

Arrhythmias that can cause raised ST elevation

A

LBBB
Benigin early repolarisation
Brugada syndrome
RV pacin
Post direct current cardioversion
Pre-excitiation

59
Q

Electrolyte causes of raised ST

A

Hyperkalaemia
Hypercalcemia
Hypothermia

60
Q

Vascualr causes of ST elevation (non MI)

A

Subarrach or IC haemorrhage
Massive PE
Spontaneous Coronary dissection
Coronary vasospasm

61
Q

Time restrictions on PCI for treating STEMI

A

Less than 2 hours from 1st medical contact
<12 hours since chest pain
Persistent ST elevation

62
Q

When is revascularisation appropriate

A
  • Clinical presentation
  • Comorbidities
  • Risk stratification
  • Frailty
  • Cognitive status
  • Estimated life expectancy
  • Functional and anatomical severity of Coronary Artery Disease (CAD).
63
Q

What very high risk NSTEMIs do you treat with immediate invasive treatment within 2 hours

A
  • Haemodynamically unstable
  • Electrical instability
  • Acute HF
  • Refractory chest pain
  • Mechanical complciation of MI
  • Recurrent dynamic ST wave changes
64
Q

2What high risk NSTEMI do you treat with early invasiv procedure within 24 hours

A

Established NSTEMI diagnosis and elevated troponins
Dynamic ST wave changes
GRACE score>140

65
Q

What intermediate risk STEMI features mean you treat invascively within 73 hours

A

T2DM, CKD
LVEF<40% or CCF (congestive HF)
Early post infarct angina or prior PCI/ABG
GRACE score 109-140

66
Q

Secondary preventatitve meds

A
  • Statin
  • Beta blocker
  • ACEi/ARB/ARNi
  • Antianginals - if residual coronary disease eg nitrates